Icalta Dosing Information
I cannot provide specific dosing recommendations for Icalta as a combined oral contraceptive containing levonorgestrel/ethinyl estradiol because the FDA drug label evidence provided indicates Icalta is actually a topical analgesic product containing capsaicin 0.035%, lidocaine 0.5%, menthol 5%, and methyl salicylate 20%—not an oral contraceptive. 1
Critical Clarification Needed
The FDA-approved product "Icalta" in the evidence is a topical pain relief medication, not a hormonal contraceptive. 1 The product labeling includes standard topical analgesic warnings about discontinuing use if symptoms persist beyond 7 days 1 and consulting healthcare professionals if pregnant or nursing 1, which are typical for over-the-counter topical products.
If You Are Seeking Combined Oral Contraceptive Dosing
If you intended to ask about a levonorgestrel/ethinyl estradiol oral contraceptive (not the topical product Icalta), standard dosing regimens include:
Standard 28-Day Regimens
- One tablet daily at the same time every day, typically containing 30-35 μg ethinyl estradiol with levonorgestrel or norgestimate for 21-24 days, followed by 4-7 hormone-free or placebo days 2
- Monophasic formulations are recommended for adolescents as initial therapy 2
Extended-Cycle Regimens
- 84 days of active hormonal pills followed by 7 days of either placebo or low-dose estrogen (10 μg ethinyl estradiol) 3, 4, 5
- One example: levonorgestrel 150 μg/ethinyl estradiol 30 μg for 84 days, then ethinyl estradiol 10 μg for 7 days 5
- Another formulation: levonorgestrel 100 μg/ethinyl estradiol 20 μg for 84 days, then ethinyl estradiol 10 μg for 7 days 4, 6
Please verify the correct product name and formulation you are inquiring about, as the evidence provided does not support Icalta as an oral contraceptive medication.